Implantable Medical Device Pacing Pulse Detection and Blanking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Subcutaneous ICD systems face challenges in detecting pacing therapy delivered by co-implanted leadless pacing devices, which can interfere with tachyarrhythmia detection and require complex communication systems to prevent unwanted ATP therapies post-defibrillation shocks.
Innovation Solution
An implantable medical device with a sensing channel, pace pulse detector, and blanking module that detects pacing pulses and modifies the sensed electrical signals to remove pacing artifacts, thereby adjusting tachyarrhythmia detection algorithms and preventing interference.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If a subcutaneous ICD system operates with a co-implanted leadless pacing device, then pacing therapy can be provided to treat bradycardia and suppress tachyarrhythmias, but the pacing pulses interfere with tachyarrhythmia detection and require complex communication systems to prevent inappropriate therapies
Solution Approach 1:
The patent introduces a pace pulse detector as an intermediary component that monitors sensing channels for pacing pulses from the leadless pacing device. This detector acts as a mediator between the pacing device and the ICD's tachyarrhythmia detection algorithm, enabling the ICD to recognize when pacing is occurring and adjust its behavior accordingly, thereby preventing inappropriate therapies without requiring complex bidirectional communication systems
Solution Approach 2:
The patent implements a feedback mechanism where the pace pulse detector continuously monitors the sensing channels and provides information about detected pacing pulses to the control module. This feedback loop allows the ICD to dynamically adjust its tachyarrhythmia detection algorithm based on the presence of pacing pulses, enabling appropriate therapy delivery while maintaining system simplicity
2Reliability
If the ICD system uses standard sensing channels to detect tachyarrhythmias, then tachyarrhythmia detection can be performed, but pacing pulses from co-implanted devices create artifacts that reduce detection accuracy
Solution Approach 1:
The patent converts the harmful effect of pacing pulses into a beneficial detection mechanism. The pace pulse detector is specifically designed to recognize the characteristic waveform patterns of pacing pulses and use this information to trigger appropriate responses, such as blanking the sensing channel or adjusting detection thresholds, thereby transforming the interference into a useful signal that improves overall detection accuracy
Solution Approach 2:
The patent dynamically changes sensing parameters based on the detection of pacing pulses. When pacing pulses are detected, the system adjusts detection thresholds, blanking periods, and algorithm parameters to account for the presence of pacing artifacts, thereby maintaining accurate tachyarrhythmia detection despite the interference from pacing therapy
Data Source
Figure 1
Figure 2
Figure 3
AI summary
In situations in which an implantable medical device (IMD) (e.g., an extravascular ICD) is co-implanted with a leadless pacing device (LPD), it may be important that the IMD knows when the LPD is delivering pacing, such as anti-tachycardia pacing (ATP). Techniques are described herein for detecting, with the IMD and based on the sensed electrical signal, pacing pulses and adjusting operation to account for the detected pulses, e.g., blanking the sensed electrical signal or modifying a tachyarrhythmia detection algorithm. In one example, the IMD includes a pace pulse detector that detects, based on the processing of sensed electrical signals, delivery of a pacing pulse from a second implantable medical device and blank, based on the detection of the pacing pulse, the sensed electrical signal to remove the pacing pulse from the sensed electrical signal.